Fluorodexyglucose SPECT in acute myocardial infarction: Case report;Tomografía SPECT con F18-fluorodeoxiglucosa en infarto reciente del miocardio. Caso clínico

Revista Medica de Chile

Volumn 128, Issue 9, 2000, Pages 1019-1023

  González E , Patricio ^a,b   Coll C, Claudia ^a   Massardo V, Teresa ^a   Sierralta C, Paulina ^a   Humeres A, Pamela ^a   Aramburú M, Ivonne ^a   Brugère O, Solange ^a   Yovanovich S, Jorge ^a   Ramírez N, Alfredo ^a   Jofré M, Josefina ^a   Chamorro B, Hernán ^a   Kuntsmann F, Sonia ^a   López B, Héctor ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Myocardial infarction; Myocardial reperfusion; Myocardial revascularization; Tomography, emission computed, single photon

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; GLUCOSE; RADIOPHARMACEUTICAL AGENT; THALLIUM;

ARTICLE; CASE REPORT; ECHOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; METABOLISM; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0347874224     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. LEE KS, MARWEK TH, COOK SA, GO RT, FIX JS, JAMES KB. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Circulation 1994; 90: 2687-94.
2. PIERARD L, DE LANDSHEERE C, BERTHE C, RIGO P, KULBERTUS H. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. JACC 1990; 1021-31.
3. SMARTIRT SC, KNICKELBIEN T, CARLOS ME, HELLMAN RS. Dobutamine echocardiography and rest SPECT Tl 201 scintigraphy are more concordant in detecting viability in hibernating than stunned myocardium. JACC 1995; 126a (abstract).
4. STEVEN C. Port Imaging Guidelines for Nuclear Cardiology Procedures, Part 2. J Nucl Cardiol 1999; 6: G47-84.
5. RAHIMTOOLA SH. The hybernating myocardium. Am Heart J 1989; 177: 211-21.
6. COLBY J, HAKK AH, ISKANDRIAN AS. Hemodynamic, angiographic and scintigraphic correlation of positive exercise electrocardiograms: emphasis on strongly positive exercise electrocardiograms. J Am Coll Cardiol 1983; 2: 21-7.
7. GONZÁLEZ P, PAWLAK M, RAGGIO R, ALLIENDE I, GARCÉS N, CHAMORRO H, OBERHAUSER E. Utilidad de la prueba de esfuerzo con Talio 201 en cardiopatía coronaria. Rev Méd Chile 1982; 110: 839-47.
8. L'ABBATE A, BIAGINI A, MICHELASSI C, DISTANTE A, MASERI A. Myocardial kinetics of thallium and potassium in man. Circulation 1979; 60: 776-85.
9. STRAUSS HW, HARRISON K, LANGAN JK, LEBOWITZ E, PITT B. Thallium 201 from myocardial imaging. Relation of Thallium 201 to regional myocardial perfusion. Circulation 1975; 51: 641-5.
10. ISKANDRIAN A, HAKKI A, KANE SA, GOEL IP, MUNDTH ED, HAKKI AH, SEGAL BL. Rest and redistribution thallium myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting. Am J Cardiol 1983; 51: 1312-6.
11. DILSIZIAN V, PERRONE-FILARDI P, ARRIGHI JA, BACHARACH SL, QUYYUMI AA, FREEDMAN NM, BONOW RO. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography. Circulation 1993; 88: 283-93.
12. INGLESE E, BRAMBILLA M, DONDI M, PIERI P, BISI G, SARA R ET AL. Assessment of myocardial viability after Thallium 201 reinjection or rest-redistribution imaging: A multicenter study. J Nucl Med 1995; 36: 555-63.
13. OHTANI H, TAMAKI N, YONEKURA Y, MOHIUDDIN I, HIRATA K, BAN T, KONISHI J. Value of thallium 201 reinjection after delayed a SPECT imaging for predicting reversible ischemia after coronary bypass grafting. Am J Cardiol 1990; 66: 394-9.
14. TAMAKI N, OHTANI H, YONEKURA Y, SHINDO M, NOHARA R, KAMBARA H ET AL. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET. J Cardiol 1992; 22: 283-93.
15. BAX J, VISSER F, VAN LINGEN A, KAMP O, VAN LEEUWEN GR, VISSER GW ET AL. Feasibility of assessing regional myocardial uptake of F-18 fluorodeoxyglucose using Single Photon Emission Computed Tomography. Eur Heart J 1993; 14: 1675-82.
16. GALLAGHER BM, FOWLER JS, GUTTERSON NI, MCGREGOR R, WAN C, WOLF A. Metabolic trappigng as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of 18-FDG. J Nucl Med 1978; 19: 1154-61.
17. SCHWAIGER M, BRUNKEN R, GROVER-MCKAY M, KRIVOKAPICH J, CHILD J, TILLISCH LH, PHELPS ME, SCHELBERT HR. Regional myocardial metabolism in patients with acute myocardial infarction assessed by PET. J Am Coll Cardiol 1986; 8: 800-8.
18. DRAEN W, ABBOTT F, NICOLE M, MASTIN S, KUPERUS J. Technology for FDG SPECT with a relatively inexpensive gammacamera. Radiology 1994; 191: 461-65.
19. BURT RW, PERKINS OW, OPPENHEIM BE, SCHAUWECKER O, STEIN L, WELLMAN H. Comparison of F-18 FDG SPECT, F-18 FDG PET and rest thallium 201 SPECT for detection of myocardial viability. J Nucl Med 1995; 36: 176-9.
20. FARAGGI M, KARILA-COHEN D, BROCHET E, LEBTAHI R, CZITROM D, FELDMAN L ET AL. Relationship between resting 201 Tl reverse redistribution , microvascular perfusion and functional recovery in acute myocardial infarction. J Nucl Med 2000; 41: 393-9.
21. YAMAGISHI H, AKIOKA K, HIRATA K, SAKANOUE Y, TAKEUCHI K, YOSHIKAWA J, OCHI H. A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction. J Nucl Med 1999; 40: 1492-8.